Synonym
MK870; MK-870; MK 870; Amiloride Hydrochloride; Midamor; Midoride; Modamide.
IUPAC/Chemical Name
Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride dihydrate
InChi Key
LTKVFMLMEYCWMK-UHFFFAOYSA-N
InChi Code
1S/C6H8ClN7O.ClH.2H2O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11;;;/h(H4,8,9,13)(H4,10,11,14,15);1H;2*1H2
SMILES Code
c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=N)N.O.O.Cl
Appearance
Light yellow to yellow solid powder.
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
302.12
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Judd EK, Calhoun DA, Warnock DG. Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channels. Semin Nephrol. 2014;34(5):532-9. doi: 10.1016/j.semnephrol.2014.08.007. Review. PubMed PMID: 25416662; PubMed Central PMCID: PMC4450367.
2: Warnock DG, Kusche-Vihrog K, Tarjus A, Sheng S, Oberleithner H, Kleyman TR, Jaisser F. Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells. Nat Rev Nephrol. 2014 Mar;10(3):146-57. doi: 10.1038/nrneph.2013.275. Epub 2014 Jan 14. Review. PubMed PMID: 24419567; PubMed Central PMCID: PMC4137491.
3: Ji HL, Zhao RZ, Chen ZX, Shetty S, Idell S, Matalon S. δ ENaC: a novel divergent amiloride-inhibitable sodium channel. Am J Physiol Lung Cell Mol Physiol. 2012 Dec 15;303(12):L1013-26. doi: 10.1152/ajplung.00206.2012. Epub 2012 Sep 14. Review. PubMed PMID: 22983350; PubMed Central PMCID: PMC3532584.
4: Matthews H, Ranson M, Kelso MJ. Anti-tumour/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty? Int J Cancer. 2011 Nov 1;129(9):2051-61. doi: 10.1002/ijc.26156. Epub 2011 Aug 1. Review. PubMed PMID: 21544803.
5: O'Brodovich H, Yang P, Gandhi S, Otulakowski G. Amiloride-insensitive Na+ and fluid absorption in the mammalian distal lung. Am J Physiol Lung Cell Mol Physiol. 2008 Mar;294(3):L401-8. Epub 2007 Dec 27. Review. PubMed PMID: 18162600.
6: Teiwes J, Toto RD. Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride. Am J Hypertens. 2007 Jan;20(1):109-17. Review. PubMed PMID: 17198922.
7: Haddad JJ. Amiloride and the regulation of NF-kappaB: an unsung crosstalk and missing link between fluid dynamics and oxidative stress-related inflammation--controversy or pseudo-controversy? Biochem Biophys Res Commun. 2005 Feb 11;327(2):373-81. Review. PubMed PMID: 15629126.
8: Swift PA, MacGregor GA. The epithelial sodium channel in hypertension: genetic heterogeneity and implications for treatment with amiloride. Am J Pharmacogenomics. 2004;4(3):161-8. Review. PubMed PMID: 15174897.
9: Hirsh AJ. Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents. Adv Drug Deliv Rev. 2002 Dec 5;54(11):1445-62. Review. PubMed PMID: 12458154.
10: Guggino WB, Guggino SE. Amiloride-sensitive sodium channels contribute to the woes of the flu. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):9827-9. Review. PubMed PMID: 10963654; PubMed Central PMCID: PMC34034.
11: Alvarez de la Rosa D, Canessa CM, Fyfe GK, Zhang P. Structure and regulation of amiloride-sensitive sodium channels. Annu Rev Physiol. 2000;62:573-94. Review. PubMed PMID: 10845103.
12: Wazny LD, Brophy DF. Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia. Ann Pharmacother. 2000 Jan;34(1):94-7. Review. PubMed PMID: 10669191.
13: Kleyman TR, Sheng S, Kosari F, Kieber-Emmons T. Mechanism of action of amiloride: a molecular prospective. Semin Nephrol. 1999 Nov;19(6):524-32. Review. PubMed PMID: 10598540.
14: Karmazyn M. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury. From amiloride to cariporide. Ann N Y Acad Sci. 1999 Jun 30;874:326-34. Review. PubMed PMID: 10415544.
15: Harris C, Fliegel L. Amiloride and the Na(+)/H(+) exchanger protein: mechanism and significance of inhibition of the Na(+)/H(+) exchanger (review). Int J Mol Med. 1999 Mar;3(3):315-21. Review. PubMed PMID: 10028059.
16: Halpern BP. Amiloride and vertebrate gustatory responses to NaCl. Neurosci Biobehav Rev. 1998;23(1):5-47. Review. PubMed PMID: 9861611.
17: Horisberger JD. Amiloride-sensitive Na channels. Curr Opin Cell Biol. 1998 Aug;10(4):443-9. Review. PubMed PMID: 9719863.
18: Hummler E. Reversal of convention: from man to experimental animal in elucidating the function of the renal amiloride-sensitive sodium channel. Exp Nephrol. 1998 Jul-Aug;6(4):265-71. Review. PubMed PMID: 9690087.
19: Voilley N, Galibert A, Bassilana F, Renard S, Lingueglia E, Coscoy S, Champigny G, Hofman P, Lazdunski M, Barbry P. The amiloride-sensitive Na+ channel: from primary structure to function. Comp Biochem Physiol A Physiol. 1997 Oct;118(2):193-200. Review. PubMed PMID: 9366043.
20: Blazer-Yost BL, Helman SI. The amiloride-sensitive epithelial Na+ channel: binding sites and channel densities. Am J Physiol. 1997 Mar;272(3 Pt 1):C761-9. Review. PubMed PMID: 9124509.
